Related by context. All words. (Click for frequent words.) 79 Peginterferon 79 Bevacizumab 78 Irinotecan 78 Gemcitabine 77 Docetaxel 77 Monotherapy 77 Fluorouracil 76 Erlotinib 76 Cyclophosphamide 75 Tolerability 75 Melphalan 75 Pemetrexed 75 mycophenolate mofetil 75 Fulvestrant 75 Posaconazole 74 Fludarabine 74 Pegylated Interferon 74 Peginterferon Alfa 2a 74 5 Fluorouracil 74 Adefovir 74 Adjuvant Treatment 74 Hormone Refractory Prostate Cancer 74 pegylated liposomal doxorubicin 74 Prolongs Survival 74 Medoxomil 74 Unfractionated Heparin 73 ACE Inhibitors 73 Double Blind Randomized 73 Pegylated Liposomal Doxorubicin 73 Meets Primary Endpoint 73 Bortezomib 73 Camptosar ® 73 efavirenz EFV 73 Decitabine 73 Paraplatin ® 73 Patients Treated With 73 Lenalidomide 73 ritonavir boosted 73 Adjuvant Therapy 73 paclitaxel Taxol 73 Patients Treated 73 Antitumor Activity 73 Nilotinib 73 Newly Diagnosed Multiple Myeloma 73 Plus Ribavirin 73 5-FU/LV 73 DOXIL 73 FOLFOX6 72 Neoadjuvant 72 Insulin Glargine 72 Mitoxantrone 72 Oral Fingolimod 72 sorafenib Nexavar 72 thalidomide Thalomid 72 Ziprasidone 72 flutamide 72 Mg Uk 72 Chemoradiation 72 Anti TNF 72 Doxil ® 72 Corticosteroid 72 5 FU leucovorin 72 Metastatic Colorectal Cancer 72 Low Dose 72 FOLFIRI 72 Alkeran 72 Epirubicin 72 Combination Therapy 72 Bicalutamide 72 Previously Treated 72 Epoetin Alfa 72 Anthracycline 72 Fondaparinux 72 SPRYCEL ® 72 Fluconazole 72 Cardiotoxicity 72 Chronic Hepatitis C 72 Pharmacokinetics PK 72 Trastuzumab 72 Refractory Hodgkin Lymphoma 72 Lamivudine 72 Lubiprostone 72 Protease Inhibitors 71 Dasatinib 71 Patients Receiving 71 Platinol ® 71 Pioglitazone 71 FASLODEX 71 unfractionated heparin UFH 71 ergot derivatives 71 erlotinib Tarceva ® 71 Renal Cell Carcinoma 71 Mg Usa 71 abacavir lamivudine 71 Peg IFN 71 Cisplatin 71 Interferon alfa 71 tenofovir Viread 71 administered subcutaneously 71 Single Dose 71 Tiotropium 71 Azathioprine 71 Relapsing Multiple Sclerosis 71 Darunavir 71 Pooled Analysis 71 Gemzar ® 71 interferon alfa 2b 71 Taxotere ® 71 cisplatin gemcitabine 71 Previously Untreated 71 Castration Resistant Prostate Cancer 71 Fluticasone 71 Gefitinib 71 nucleoside analog 71 Natalizumab 71 PEGASYS ® 71 FOLFOX4 71 Metastatic Prostate Cancer 71 adalimumab Humira 71 Study Evaluating 71 Benign Prostatic Hyperplasia 71 Aliskiren 71 Antiviral Activity 71 lopinavir r 71 alpha 2a 71 Metastatic Melanoma 71 liposomal amphotericin B 71 Extended Release 71 Bivalirudin 71 Topotecan 71 Pharmacokinetic Study 71 Advanced Melanoma 71 estramustine 71 Glatiramer Acetate 71 Leucovorin 71 adriamycin 71 alfa 2a 71 ZOLINZA 71 Disease Progression 70 Improves Survival 70 relapsed MM 70 Bosentan 70 salmeterol fluticasone 70 Dapagliflozin 70 Mesalamine 70 Aflibercept 70 saline placebo 70 Tipranavir 70 abacavir Ziagen 70 Copegus ribavirin 70 voriconazole 70 FUSILEV enhances 70 6 mercaptopurine 70 Doxorubicin 70 Interferon Beta 70 Well Tolerated 70 Recombinant Human 70 Oxaliplatin 70 BARACLUDE ® 70 Moxifloxacin 70 Fixed Dose 70 Ribavirin 70 docetaxel Taxotere ® 70 Peginterferon alfa 2b 70 Darusentan 70 Vidaza azacitidine 70 Tacrolimus 70 carboplatin paclitaxel 70 Boceprevir 70 Protease Inhibitor 70 JAK Inhibitor 70 Disease Modifying 70 Carboplatin 70 Azacitidine 70 Naive Patients 70 Interferon Alpha 70 Enoxaparin 70 Nebulized 70 dacarbazine 70 ritonavir boosted atazanavir 70 Improved Survival 70 glatiramer acetate 70 Survival Benefit 70 8mg/kg 70 clotrimazole 70 Adjuvant Chemotherapy 70 Is Well Tolerated 70 Anti Tumor Activity 70 Itraconazole 70 fluorouracil 70 ara C 70 ethambutol 70 Investigational Compound 70 Xeloda ® 70 candesartan cilexetil 70 amprenavir 70 Postmenopausal Osteoporosis 70 #mg/#mg 70 Mycophenolate Mofetil 70 Vildagliptin 70 bleomycin 70 Randomized Double Blind 70 PEG IFN 70 Complicated Skin 70 Amlodipine 70 Investigational Treatment 70 Improves Outcomes 70 Anti Tumor 70 Demonstrates Potent 70 Phase 2b Clinical Trial 70 Exemestane 70 Interferon beta 1a 70 Pegylated 70 cyclophosphamide methotrexate 70 alkylating agent 70 Cytarabine 70 Investigational Drug 70 PRN FDA Approves 70 chemotherapy cisplatin 70 Drug Candidate 70 Shows Efficacy 70 Sulfonylurea 69 Placebo Controlled Study 69 ribavirin USP 69 Phase IIb Trial 69 GW# [003] 69 Adalimumab 69 Efficacious 69 APTIVUS r 69 Cilostazol 69 Rituximab 69 administered concomitantly 69 Combination Treatment 69 amphotericin B 69 Placebo Controlled Trial 69 Taxol ® 69 Prophylaxis 69 Losartan 69 nicardipine 69 Navelbine ® 69 Relapsed Refractory Multiple Myeloma 69 Adjunctive Therapy 69 Temozolomide 69 TAXOTERE R 69 Orally administered 69 Statistically Significant 69 Treated Patients 69 Infliximab 69 DMARDS 69 cetuximab Erbitux R 69 Tarceva TM 69 interferon alfa 2a 69 Parathyroid Hormone 69 tenofovir emtricitabine 69 Phase 2b Study 69 Zoledronic Acid 69 tigecycline 69 dexamethasone Decadron 69 Salmeterol 69 gefitinib Iressa 69 Nucleoside 69 Controlled Trial 69 trabectedin 69 tolterodine ER 69 Xelox 69 peginterferon alpha 2a 69 daunorubicin 69 Anastrozole 69 Soft Tissue Sarcoma 69 doxorubicin cyclophosphamide 69 etanercept Enbrel 69 Interferon Alfa 69 oral rivaroxaban 69 Zorbtive TM 69 AZT zidovudine Retrovir 69 Platinol ® cisplatin 69 BENICAR HCT 69 Relapsed Refractory 69 gemcitabine Gemzar 69 Hsp# Inhibitor 69 melphalan prednisone 69 Ibritumomab Tiuxetan 69 antiandrogen 69 Receptor Antagonists 69 infliximab Remicade 69 prucalopride 69 meropenem 69 Advanced Prostate Cancer 69 CAELYX 69 Daptomycin 69 Abacavir 69 clodronate 69 Clopidogrel 69 oral prodrug 69 mesalazine 69 Ambrisentan 69 Myelodysplastic Syndrome MDS 69 Ozarelix 69 INFERGEN 69 acitretin 69 Dexamethasone 69 Initiate Clinical Trial 69 Celecoxib 69 Advanced Renal Cell 69 Elderly Patients 69 Pegasys ® 69 Orally Active 69 sulfasalazine 69 cidofovir 69 Tumor Response 69 liposomal doxorubicin 69 chemoradiation therapy 69 Long Term Efficacy 69 HCV Genotype 69 Demonstrates Efficacy 69 idarubicin 69 Taxotere R 69 lamivudine 3TC 69 mapatumumab 69 Corticosteroids 69 octreotide acetate 69 Pivotal Phase III 69 TPV r 69 amifostine 69 Methotrexate 69 gemcitabine cisplatin 69 pyrazinamide 68 Tasigna nilotinib 68 doxazosin 68 Sitagliptin 68 Amikacin 68 Pivotal Phase 68 aspirin clopidogrel 68 4mg/kg 68 lapatinib Tykerb 68 Tocilizumab 68 Lamotrigine 68 zidovudine AZT 68 metastatic malignant 68 Velcade bortezomib 68 1mg 2mg 68 Cyclosporine 68 Ramipril 68 Treatment Naive Patients 68 piroxicam 68 Bevacizumab Avastin 68 TNF Tumor Necrosis Factor 68 bevacizumab Avastin 68 Vinorelbine 68 Colorectal Cancer Patients 68 Advanced Pancreatic Cancer 68 Hepatitis C Genotype 68 Phase III Clinical Trial 68 XELOX 68 Hycamtin ® 68 Epivir 68 Clinical Trial Results 68 Bisphosphonate 68 Demonstrated Significant 68 Telbivudine 68 Antitumor 68 trimethoprim sulfamethoxazole 68 Angiotensin Converting Enzyme 68 alefacept 68 Voreloxin 68 Anticoagulant 68 R lenalidomide 68 PEGylated Fab fragment 68 Transdermal Patch 68 Neulasta ® 68 Budesonide 68 denileukin diftitox 68 Amrubicin 68 IND Application 68 Pazopanib 68 Lopinavir 68 paroxetine Paxil 68 zoledronate 68 biologic DMARD 68 Hydrochlorothiazide 68 Diabetic Neuropathy 68 Carvedilol 68 NeoRecormon 68 conventional DMARDs 68 risedronate Actonel 68 Regimens 68 DOXIL ® 68 Androgen Deprivation Therapy 68 CANCIDAS 68 mg qd 68 Cutaneous T 68 bevacizumab Avastin R 68 pegylated interferon alfa 2a 68 Folfox 68 Danazol 68 Navelbine 68 Pafuramidine 68 ceftazidime 68 Hepatocellular Carcinoma 68 5 fluorouracil leucovorin 68 Vincristine 68 receptor tyrosine kinase inhibitor 68 Versus Placebo 68 cetuximab Erbitux ® 68 Xeloda capecitabine 68 Sapacitabine 68 protease inhibitor PI 68 Hypertensive Patients 68 ddI 68 pegylated interferon alpha 2a 68 epirubicin 68 HMG CoA reductase inhibitors 68 Chronic Sinusitis 68 radiotherapy RT 68 galiximab 68 cinacalcet 68 LYSTEDA 68 miconazole 68 ganciclovir 68 3TC lamivudine Epivir 68 HDAC Inhibitor 68 terfenadine 68 Valopicitabine 68 Etanercept 68 fluticasone furoate 68 Randomized Phase 68 mitoxantrone plus 68 trastuzumab Herceptin 68 dasatinib Sprycel ® 68 Fludara 68 Diabetic Foot Ulcer 68 imipenem 68 Tigecycline 68 Ranolazine 68 pegylated interferon alfa 68 Gastrointestinal Stromal Tumors 68 idraparinux 68 Zoledronic acid 68 Epidermal Growth Factor Receptor 68 Metronidazole 68 interferon gamma 1b 68 Taxotere docetaxel 68 Advanced Colorectal Cancer 68 AZT 3TC 68 Entecavir 68 Traficet EN 68 mitoxantrone chemotherapy 68 Alpha interferons including 68 tocilizumab 68 5FU 68 letrozole Femara 68 leukotriene receptor antagonist 68 ORENCIA ® 68 Elitek 68 mycophenolic acid 68 Anticancer Activity 68 Lansoprazole 68 Fingolimod 68 sorafenib tablets 68 Inhaled Corticosteroids 68 Investigational Agent 68 #mg BID [003] 68 Sevelamer 68 vincristine doxorubicin 68 pan HDAC inhibitor 68 Antihistamine 68 gemcitabine carboplatin 68 Elotuzumab 68 intravenously administered 68 Resistant Hypertension 68 Rheumatoid Arthritis Patients 68 tamoxifen citrate 67 Immunosuppression 67 Eltrombopag 67 Intravitreal 67 Cytotoxic 67 fluoropyrimidine 67 nitrofurantoin 67 evaluating tivozanib 67 injected subcutaneously 67 ibandronate 67 Clinical Efficacy 67 ZYVOX 67 azathioprine 67 azacytidine 67 nab paclitaxel 67 Interferon beta 1b 67 Overactive Bladder 67 Indomethacin 67 Prophylactic Treatment 67 Autologous Stem Cell Transplantation 67 INTEGRILIN R 67 ULORIC 67 docetaxel Taxotere 67 Sporanox 67 dose cytarabine 67 Temsirolimus 67 sertraline Zoloft 67 LT NS# 67 nucleoside reverse transcriptase inhibitor 67 platelet inhibitor 67 Percutaneous Tibial Nerve Stimulation 67 antifibrinolytic 67 irbesartan 67 IFN beta 67 Antiviral Therapy 67 Temodar ® 67 Hycamtin 67 Antifungal 67 Teriflunomide 67 LOVENOX R 67 Fibrates 67 divalproex sodium 67 VAPRISOL 67 Phase III Trial 67 ATACAND 67 Retreatment 67 Diffuse Large B 67 Filgrastim 67 octreotide LAR 67 docetaxel chemotherapy 67 Fewer Side Effects 67 alpha interferons 67 Pediatric Patients 67 Aurora Kinase 67 Safinamide 67 Significantly Improved 67 xanthine oxidase inhibitor 67 Degarelix 67 Tanespimycin 67 FOLPI 67 indinavir 67 H2 antagonists 67 See CLINICAL PHARMACOLOGY 67 Bezielle 67 capecitabine Xeloda 67 fluticasone salmeterol 67 angiotensin receptor blocker ARB 67 ® lenalidomide 67 miconazole Lauriad ® 67 Metastatic Renal Cell Carcinoma 67 Golimumab 67 oral clodronate 67 atorvastatin #mg 67 Demonstrates Significant 67 paricalcitol 67 PEGINTRON TM 67 TYGACIL 67 Prilosec omeprazole 67 Levofloxacin 67 fluorouracil leucovorin 67 rizatriptan 67 stage IIIB 67 Bosutinib 67 pamidronate 67 Advanced Solid Tumors 67 caspofungin 67 Initiate Phase 67 captopril 67 standard chemotherapy regimen 67 Relapsing Remitting Multiple Sclerosis 67 ß blockers 67 cefuroxime 67 interferon ribavirin 67 pyridostigmine 67 Sirolimus Eluting 67 ribavirin RBV 67 HER2 Positive Breast Cancer 67 piperacillin tazobactam 67 PEGylated anti 67 TEMODAL 67 #.#mg/dL 67 benazepril 67 Trial Evaluating 67 chlorambucil 67 Radioimmunotherapy 67 APTIVUS 67 sunitinib Sutent ® 67 gastrointestinal stromal tumors GIST 67 Phase IIa Clinical Trial 67 pharmacokinetic interactions 67 TYKERB 67 Venlafaxine 67 Paclitaxel Carboplatin 67 terazosin 67 Preclinical Data 67 Antipsychotic 67 macrolide antibiotic 67 busulfan 67 Malignant Glioma 67 Everolimus 67 BANZEL 67 Glufosfamide 67 reuptake inhibitor 67 Severe Sepsis 67 betamethasone dipropionate 67 Fracture Risk 67 Telithromycin 67 Teriparatide 67 Sustiva efavirenz 67 pemetrexed 67 liposomal formulation 67 Famotidine 67 trans retinoic acid 67 REYATAZ R 67 Sandostatin R 67 colorectal liver metastases 67 pegylated interferon alpha 67 Glatiramer acetate 67 Adjunctive 67 Treatment Naive 67 Pegylated interferon 67 Presents Preclinical Data 67 Pulmonary Arterial Hypertension 67 antiepileptics 67 Inhalation Aerosol 67 fluvastatin 67 TMP SMX 67 Novel Oral 67 Mantle Cell Lymphoma 67 angiotensin converting enzyme inhibitors 67 Carbamazepine 67 PegIFN RBV 67 Hormone Receptor Positive 67 Peginterferon alfa 2a 67 Vaprisol 67 Tyrosine Kinase Inhibitor 67 Ganciclovir 67 Atypical Hemolytic Uremic Syndrome 67 demonstrated antitumor activity 67 venlafaxine Effexor 67 tipranavir 67 Nitazoxanide 67 Demonstrates Potential 67 Methylnaltrexone 67 labetalol 67 Raltegravir 67 ritonavir boosted protease inhibitor 67 Myelofibrosis 67 lenalidomide dexamethasone 67 panitumumab Vectibix 67 Cytoxan 67 Patients Undergoing 67 Newly Diagnosed 67 bortezomib Velcade 67 Topical Gel 67 rabeprazole 67 Epratuzumab 67 CHOP chemotherapy 67 Plaque Psoriasis 67 Kinase Inhibitor 67 Abciximab 67 2 methoxyestradiol 67 COPEGUS R 67 carmustine 67 alendronate Fosamax 67 imatinib Gleevec ® 67 Laquinimod 67 Peginterferon Alfa 2b 67 imiquimod cream 67 Completes Patient Enrollment 67 Alendronate 67 Study Showed 67 PEGylated interferon beta 1a 67 Follicular Lymphoma 67 selective phosphodiesterase 67 TO AVOID PREGNANCY WHILE 67 Relapsed Multiple Myeloma 67 Atazanavir 67 steroid dexamethasone 67 paclitaxel carboplatin 67 FDA Approvals 67 Demonstrates Positive 67 GP IIb IIIa inhibitors 67 COMBIVIR 67 doxorubicin HCl liposome injection 66 Camptosar ® irinotecan 66 ZACTIMA 66 Cardiovascular Events 66 Vandetanib 66 PKC# 66 MYCAMINE 66 Haemophilus b Conjugate 66 interferon alfa 66 Sirolimus Eluting Stent 66 Toxicities 66 Copegus ® 66 Tesamorelin 66 diclofenac Voltaren 66 Ketorolac 66 Dose Escalation 66 DFMO 66 Combination therapy 66 efavirenz Sustiva 66 Liposomal 66 beta 1a 66 Acute Ischemic Stroke 66 Benazepril 66 itraconazole Sporanox 66 Helicobacter pylori eradication 66 Taxol paclitaxel 66 Betaferon R 66 anthracyclines taxanes 66 Subcutaneous 66 Parnate 66 Phase III Trials 66 Maribavir 66 Cyclooxygenase 2 66 rFSH 66 Hydrochloride Injection 66 Viread Emtriva 66 ABVD 66 Prospective Randomized 66 leflunomide 66 Treatment Regimen 66 Torisel 66 Ecallantide 66 Montelukast 66 metastatic GIST 66 Ropinirole 66 Myelodysplastic Syndromes 66 paclitaxel Taxol R 66 infusional 66 Taxotere chemotherapy 66 Phase 2a Clinical Trial 66 CIMZIA ™ 66 Allergic Rhinitis 66 Tablet Formulation 66 Treatment Naïve Patients 66 Certolizumab 66 goserelin 66 aripiprazole Abilify 66 Radiofrequency Ablation RFA 66 ARIMIDEX 66 lenalidomide Revlimid R 66 Esomeprazole 66 Clevudine 66 zafirlukast 66 Unresectable 66 Panzem R 66 COPEGUS 66 superficial bladder cancer 66 clomipramine 66 Dual Opioid 66 Etoposide 66 Oritavancin 66 Methylprednisolone 66 cyclophosphamide doxorubicin vincristine 66 Dabigatran etexilate 66 Dose Ranging Study 66 Squamous 66 LHRH agonists 66 Inhalation Solution 66 danazol 66 NICE Recommends 66 medroxyprogesterone acetate 66 Pharmacodynamics 66 Toremifene 66 Antiangiogenic 66 zonisamide SR 66 BEACOPP 66 GlaxoSmithKline Requip 66 deferoxamine 66 olmesartan 66 Levoleucovorin 66 cholestyramine 66 Immunosuppressant 66 Febuxostat 66 rHuEPO 66 #mg #mg #mg [003] 66 Sustained Release 66 sunitinib Sutent 66 Diabetic Patients 66 TLK# 66 Ranibizumab 66 Imatinib 66 plus prednisone 66 Non Inferiority 66 mycophenolate mofetil MMF 66 II Clinical Trial 66 Zileuton 66 nonnucleoside reverse transcriptase inhibitors 66 Saquinavir 66 tenofovir DF 66 MAGE A3 ASCI 66 Sorafenib 66 FOLFIRI alone 66 Oral Formulation 66 peginterferon alfa 2a Pegasys 66 hydroxymethyl coenzyme 66 mertansine 66 Contrast Agents 66 Chronic Hepatitis B 66 CYP#A# substrate 66 Rifampin 66 Fludara ® 66 Granulocyte Colony Stimulating Factor 66 Eszopiclone 66 biliary tract cancer 66 NDA Submission 66 Viral Load 66 chlorthalidone 66 dasatinib Sprycel 66 omeprazole Prilosec 66 Gliadel Wafer 66 Potent Anti 66 Hydroxyurea 66 GAMMAGARD LIQUID 66 Kidney Function 66 mitoxantrone 66 Glimepiride 66 Heart Failure Patients 66 maximally tolerated dose 66 selective modulator 66 bendamustine 66 ACTEMRA TM 66 Phase IIb Clinical Trial 66 Indacaterol 66 Non Responders 66 Receptor Agonist 66 dihydrochloride 66 paclitaxel poliglumex 66 Lacosamide 66 Tumor Necrosis Factor 66 chemoradiotherapy 66 Zidovudine 66 Calcitonin 66 pioglitazone HCl 66 adalimumab 66 conjugated estrogens 66 Enalapril 66 Dacogen decitabine 66 Noxafil 66 Soriatane 66 Albuferon TM 66 pimecrolimus 66 temsirolimus Torisel 66 CIMZIA TM 66 beta2 agonist 66 anthracycline taxane 66 mitomycin C 66 Pfizer Sutent 66 MEK Inhibitor 66 Lanthanum Carbonate 66 Sanofi Aventis Taxotere 66 boosted protease inhibitor 66 Pegintron 66 pimozide 66 chemotherapy docetaxel 66 mRCC 66 Non Steroidal Anti Inflammatory 66 topically administered 66 dalteparin 66 Chronic Myeloid Leukemia 66 LPV r 66 Phase 2b Trial 66 HER2 Positive 66 Hepatic Encephalopathy 66 vinorelbine 66 immunomodulatory therapy 66 Telmisartan 66 Oxybutynin 66 Infected Patients 66 trastuzumab Herceptin ® 66 Oral Mucositis 66 Gemzar gemcitabine 66 benign prostatic hypertrophy BPH 66 insulin glulisine 66 lispro 66 anti angiogenic agent 66 nevirapine Viramune 66 Linagliptin 66 Renal Impairment 66 XYOTAX TM 66 Pertuzumab 66 TORISEL 66 tamsulosin 66 FDA Okays 66 Cethromycin 66 taxotere 66 epoetin beta 66 metformin sulfonylurea 66 decitabine 66 assessing T DM1 66 advanced hepatocellular carcinoma 66 Taxane 66 ketoconazole 66 alpha blocker 66 β blockers 66 tacrolimus ointment 66 Progressive Multifocal Leukoencephalopathy 66 Hydrochlorothiazide Tablets 66 Generic Version 66 metastatic renal cell carcinoma 66 Brain Metastases 66 Novel Mechanism 66 Lupus Nephritis 66 Interferon alpha 66 Myeloma Patients 66 Oropharyngeal Candidiasis 66 fluticasone propionate FP 66 raloxifene Evista 66 sulindac 66 #mg dose [003] 66 Adjuvant chemotherapy 66 Anti Angiogenic 66 Fenofibrate 66 plus COPEGUS 66 Valproate 66 fosbretabulin 66 bicalutamide 66 Mitomycin C 66 Ritonavir 66 Doxil 66 Flu Cy 66 Prograf ® 66 IXEMPRA 66 q#h 66 Risperidone 66 Immunomodulatory 66 Randomized Phase II 66 luteinizing hormone releasing 66 palifermin 66 AZILECT 66 Phase 2a Trial 66 stage IIIb IV 66 Interferon alpha 2b 66 LHRH 66 anti androgen 66 Didanosine 66 lanthanum carbonate 66 Randomized Clinical Trial 66 PREMPRO 66 tenofovir disoproxil fumarate Viread 66 lansoprazole Prevacid 66 Tenormin 66 STELARA TM 65 ZD# [001] 65 Emtriva Viread 65 comparator arm 65 Hepatitis C Patients 65 certolizumab 65 BAL# [002] 65 β blocker 65 Kinoid 65 HuMax EGFr 65 Valsartan 65 PegIFN 65 Bronchodilator 65 tiotropium bromide 65 azacitidine 65 Seliciclib 65 Allopurinol 65 PEG interferon 65 simvastatin #mg 65 Solid Tumors 65 Antiplatelet 65 REVLIMID ® 65 Cellcept 65 5alpha reductase 65 Bare Metal Stents 65 Femara letrozole 65 adefovir dipivoxil 65 Relapsed 65 pegylated interferons 65 orally administered inhibitor 65 colesevelam HCl 65 Initiates Clinical Trial 65 eplerenone 65 haloperidol Haldol 65 potentially hepatotoxic 65 Roche Herceptin 65 Gastric Cancer 65 fludarabine 65 pharmacologically active isomer 65 Darinaparsin 65 peginterferon alfa 65 TNF inhibitor 65 oxaliplatin Eloxatin 65 Linezolid 65 Appears Safe 65 Vitro Activity 65 Gilead Viread 65 Ixabepilone 65 Knee Osteoarthritis 65 antithymocyte globulin 65 Xanafide 65 Clindamycin 65 RISPERDAL ® 65 Allogeneic 65 Node Positive 65 epirubicin cisplatin 65 Hydralazine 65 Trabectedin 65 Prospective Randomized Trial 65 vapreotide acetate 65 dopamine partial agonist 65 Clinical Trial Evaluating 65 Acetate Rectal Suppositories